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QTc Dispersion, Hyperglycemia,
and Hyperinsulinemia
To the Editor:
QTc dispersion is an important predictor of cardiac mortality.
In the Rotterdam Study,1 persons in the highest tertile (.60 ms)
relative to the lowest tertile (,39 ms) of QTc dispersion had a
2-fold risk of cardiac death. The Rotterdam Study also confirms
that QTc dispersion is larger in diabetic than in nondiabetic
persons. QTc duration and QTc dispersion are associated with
plasma glucose and insulin levels,2 but their relative contribu-
tions to each are still unclear. We evaluated the effect of acute
hyperglycemia, with or without the accompanying hyperinsulin-
emia, on QTc duration and QTc dispersion in normal subjects.
We studied 27 healthy volunteers (17 men and 15 women)
aged 4966 years (mean6SD). All subjects were given a hyper-
glycemic glucose clamp in which plasma glucose concentrations
were acutely raised with a bolus injection of 0.33 g/kg glucose
(50% solution) followed by a 30% glucose infusion to achieve
steady-state plasma glucose levels of '15 mmol/L for 120
minutes. On another occasion, which was separated from the first
by at least a 3-day interval and in random order, the subjects
underwent the same hyperglycemic clamp plus octreotide admin-
istration (25 mg as IV bolus followed by a 0.5 mg/min infusion)
to block the release of endogenous insulin. All tests were made
with the aid of an artificial pancreas (Biostator). Electrocardio-
grams were recorded with a standard resting 12-lead ECG at
50 mm/s. QT interval analysis was done by a cardiologist who
was blinded regarding other information. QT intervals were
corrected with Bazett’s formula (QTc5QT/R-R); QTc dispersion
was calculated as the interlead variability of QTc interval (QTc
dispersion5QTcmax2QTcmin).
During clamp administration, plasma glucose stabilized at
15 mmol/L, and plasma insulin showed a biphasic pattern of
response, with an early rise at 10 minutes (327689 pmol/L)
followed by a gradual and sustained increase (4566120 pmol/L).
QTc increased from 413626 to 442629 ms (P,0.05) at the end
of the clamp administration, and QTc dispersion increased from
3269 to 55612 ms (P,0.01). Basal and clamped plasma
glucose levels in the octreotide study were not significantly
different from those of the control study; glucose-stimulated
insulin responses were markedly reduced by octreotide (105636
pmol/L at 10 minutes and 57616 pmol/L at 120 minutes). QTc
and QTc dispersion increases in the octreotide study did not
differ from those recorded in the control study.
Acute hyperglycemia in normal subjects produces significant
increases of QTc and QTc dispersion that persist during oct-
reotide infusion, which suggests a minor role for insulin. Hyper-
glycemia may induce QT changes by increasing the cytosolic
calcium content,3 by stimulating sympathetic activity,4 or both.
These results may offer a novel mechanism through which
hyperglycemia may add to the elevated cardiovascular risk of the
diabetic patient.
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Our report from the Rotterdam Study mainly concerns the
prognostic association of QTc dispersion with future cardiac
morbidity and mortality. Our study was not suitable for eluci-
dating the mechanism underlying this association. Drs Marfella,
Rossi, and Gugliamo report a study that attempts to clarify part
of the mechanism leading to prolonged QTc and increased QTc
dispersion. However, caution should be taken interpreting the
data because other factors, such as the intrinsic effects of
octreotide or the change of electrolyte levels associated with
massive glucose uptake, may also affect ventricular repolariza-
tion. We thank Drs Marfella, Rossi, and Guigliano for providing
these interesting results, and we look forward to future results.
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